NURS 6630 ASSESSING AND TREATING PATIENTS WITH IMPULSIVITY, COMPULSIVITY, AND ADDICTION ASSIGNMENT
Sample Answer for NURS 6630 ASSESSING AND TREATING PATIENTS WITH IMPULSIVITY, COMPULSIVITY, AND ADDICTION ASSIGNMENT Included After Question
Impulsivity, compulsivity, and addiction are challenging disorders for patients across the life span. Impulsivity is the inclination to act upon sudden urges or desires without considering potential consequences; patients often describe impulsivity as living in the present moment without regard to the future (MentalHelp.net, n.d.). Thus, these disorders often manifest as negative behaviors, resulting in adverse outcomes for patients. For example, compulsivity represents a behavior that an individual feels driven to perform to relieve anxiety (MentalHelp.net, n.d.). The presence of these behaviors often results in addiction, which represents the process of the transition from impulsive to compulsive behavior.
In your role as the psychiatric nurse practitioner (PNP), you have the opportunity to help patients address underlying causes of the disorders and overcome these behaviors. For this Assignment, as you examine the client case study in this week’s Learning Resources, consider how you might assess and treat clients presenting with impulsivity, compulsivity, and addiction.
Reference: MentalHelp.net. (n.d.). Impaired decision-making, impulsivity, and compulsivity: Addictions’ effect on the cerebral cortex. https://www.mentalhelp.net/addiction/impulsivity-and-compulsivity-addictions-effect-on-the-cerebral-cortex/
Resources
Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources.
WEEKLY RESOURCES
Learning Resources
- Kelly, J. E., & Renner, J. A. (2016). Alcohol-Related disorders. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), Massachusetts General Hospital psychopharmacology and neurotherapeutics (pp. 163–182). Elsevier.
- Renner, J. A., & Ward, N. (2016). Drug addiction. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), Massachusetts General Hospital psychopharmacology and neurotherapeutics (pp. 163–182). Elsevier.
- Substance Abuse and Mental Health Services Administration. (1999). Treatment of adolescents with substance use disorders: Treatment improvement protocol series
- Chapter 1, “Substance Use Among Adolescents”
- Chapter 2, “Tailoring Treatment to the Adolescent’s Problem”
- Chapter 7, “Youths with Distinctive Treatment Needs”
- University of Michigan Health System. (2016). Childhood trauma linked to worse impulse control. Journal of Psychosocial Nursing & Mental Health Services
- Links to an external site., 54(4), 15.
- Grant, J. E., Odlaug, B. L., & Schreiber, L. N. (2014). Pharmacological treatments in pathological gambling. British Journal of Clinical Pharmacology
- Links to an external site., 77(2), 375–381. https://doi.org/10.1111/j.1365-2125.2012.04457.x
- Hulvershorn, L. A., Schroeder, K. M., Wink, L. K., Erickson, C. A., & McDougle, C. J. (2015). Psychopharmacologic treatment of children prenatally exposed to drugs of abuse. Human Psychopharmacology
- Links to an external site., 30(3), 164–172. https://doi.org/10.1002/hup.2467
- Loreck, D., Brandt, N. J., & DiPaula, B. (2016). Managing opioid abuse in older adults: Clinical considerations and challenges. Journal of Gerontological Nursing
- Links to an external site., 42(4), 10–15. https://doi.org/10.3928/00989134-20160314-04
- Salmon, J. M., & Forester, B. (2012). Substance abuse and co-occurring psychiatric disorders in older adults: A clinical case and review of the relevant literature. Journal of Dual Diagnosis
- Links to an external site., 8(1), 74–84. https://doi.org/10.1080/15504263.2012.648439
- Sanches, M., Scott-Gurnell, K., Patel, A., Caetano, S. C., Zunta-Soares, G. B., Hatch, J. P., Olvera, R., Swann, A. C., & Soares, J. C. (2014). Impulsivity in children and adolescents with mood disorders and unaffected offspring of bipolar parents. Comprehensive Psychiatry
- Links to an external site., 55(6), 1337–1341. https://doi.org/10.1016/j.comppsych.2014.04.018
Medication Resources
- U.S. Food & Drug Administration. (n.d.). Drugs@FDA: FDA-approved drugs
- Links to an external site.. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
Links to an external site.
Note: To access the following medications, use the Drugs@FDA resource. Type the name of each medication in the keyword search bar. Select the hyperlink related to the medication name you searched. Review the supplements provided and select the package label resource file associated with the medication you searched. If a label is not available, you may need to conduct a general search outside of this resource provided. Be sure to review the label information for each medication as this information will be helpful for your review in preparation for your Assignments.
Click here to ORDER an A++ paper from our Verified MASTERS and DOCTORATE WRITERS: NURS 6630 ASSESSING AND TREATING PATIENTS WITH IMPULSIVITY, COMPULSIVITY, AND ADDICTION ASSIGNMENT
|
Required Media
Note: This case study will serve as the foundation for this week’s Assignment.
- Lupi, M., Martinotti, G., Acciavatti, T., Pettorruso, M., Brunetti, M., Santacroce, R., Cinose, E., Di Iorio, G., Di Nicola, M., & Di Giannantonio, M. (2014). Pharmacological treatments in gambling disorder: A qualitative review. Biomed Research International, 2014
Links to an external site.. https://doi.org/10.1155/2014/537306
To prepare for this Assignment:
- Review this week’s Learning Resources, including the Medication Resources indicated for this week.
- Reflect on the psychopharmacologic treatments you might recommend for the assessment and treatment of patients requiring therapy for impulsivity, compulsivity, and addiction.
The Assignment: 5 pages
Examine Case Study: A Puerto Rican Woman With Comorbid Addiction. You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client’s pharmacokinetic and pharmacodynamic processes.
At each decision point, you should evaluate all options before selecting your decision and moving throughout the exercise. Before you make your decision, make sure that you have researched each option and that you evaluate the decision that you will select. Be sure to research each option using the primary literature.
Introduction to the case (1 page)
- Briefly explain and summarize the case for this Assignment. Be sure to include the specific patient factors that may impact your decision making when prescribing medication for this patient.
Decision #1 (1 page)
- Which decision did you select?
- Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
- Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
- What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
- Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
Decision #2 (1 page)
- Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
- Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
- What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
- Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
Decision #3 (1 page)
- Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
- Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
- What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
- Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
Conclusion (1 page)
- Summarize your recommendations on the treatment options you selected for this patient. Be sure to justify your recommendations and support your response with clinically relevant and patient-specific resources, including the primary literature.
Note: Support your rationale with a minimum of five academic resources. While you may use the course text to support your rationale, it will not count toward the resource requirement. You should be utilizing the primary and secondary literature.
Reminder : The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The Sample Paper provided at the Walden Writing Center provides an example of those required elements (available at https://academicguides.waldenu.edu/writingcenter/templates/general#s-lg-box-20293632). All papers submitted must use this formatting
By Day 7
Submit your Assignment.
submission information
Before submitting your final assignment, you can check your draft for authenticity. To check your draft, access the Turnitin Drafts from the Start Here area.
- To submit your completed assignment, save your Assignment as WK10Assgn1_LastName_Firstinitial
- Then, click on Start Assignment near the top of the page.
- Next, click on Upload File and select Submit Assignment for review.
A Sample Answer For the Assignment: NURS 6630 ASSESSING AND TREATING PATIENTS WITH IMPULSIVITY, COMPULSIVITY, AND ADDICTION ASSIGNMENT
Title: NURS 6630 ASSESSING AND TREATING PATIENTS WITH IMPULSIVITY, COMPULSIVITY, AND ADDICTION ASSIGNMENT
The case study is about a 53-year-old Puerto Rican female who came to the clinic with an “embarrassing condition.” She has struggled with drinking ever since she lost her father in her 20s. The client claims that she has been in occasional touch with an AA group for close to 25 years. She alleges that she struggles with remaining sober and that since a neighboring casino came up close to her home two years ago, her issues have become worse. She fears that her gambling addiction has increased her likelihood of smoking, but she finds it difficult to stop drinking while she plays since it makes her feel “cool.” The number of beverages has climbed as a result of two every night.
Several factors may influence the client’s treatment. It is critical to ascertain if drug interactions might impact the pharmacodynamics, or mechanism of action, of the therapy. Take the opioid antagonist Vivitrol, for instance. Therefore, it is essential to determine whether a patient has an opioid addiction or is taking any medications that are related to opioids before giving them Vivitrol (Trick & Le Foll, 2020). Before taking Vivitrol, the client must have abstained from opioids for at least 7 to 10 days. Age, gender, race, and any restrictions on the individual must all be considered. Vivitrol’s pharmacokinetics, for instance, provides comprehensive details on how it affects biological sex, ethnicity, and age; nevertheless, caution is advised when giving it to individuals with moderate to severe renal deficiencies (Yang et al., 2022).The purpose of this discussion is tochoose the best treatments for the patient while detailing the expected outcomes and any moral conundrums at each stage of the decision-making process.
Decision #1
Selected Decision
Every four weeks, the patient would get 380 mg of Vivitrol intramuscularly (IM) into the gluteal area.
Justification
Alcohol and drug dependency are treated with the help of the extended-release naltrexone formulation Vivitrol (Zein & Itai Danovitch, 2023). The drug is taken every month (Yang et al., 2022). In 2006, the American Food and Drug Administration granted its first approval for the treatment of alcohol abuse disorder (Pettorruso et al., 2023). The beginning dosage, which aims to change how the brain reacts to alcohol usage, is 380 mg (Trick & Le Foll, 2020). Even though the client has not revealed any medications with opioids as well as other opiate addictions, the FDA states that Vivitrol is considered unsafe in patients who are experiencing opioid symptoms of withdrawal (Taubin et al., 2022). I also chose Vivitrol since it is neither narcotic nor addictive.
Reasons to Reject the Other Two Options
Decisions two and three might be utilized for people who misuse alcohol, but I chose against them since they required to be given to someone clean for some time. The patient’s degree of compliance may be impacted by the disulfiram formulation’s short half-life and higher risk of adverse effects including palpitations (Antonelli et al., 2022). Acamprosate is similarly short-acting and needs more frequent dosing, which could make it difficult for patients to adhere to the necessary dose (Mistarz et al., 2021).
Expected Outcome
After taking this medication, it is hoped that the patient will have reductions in the symptoms present at the beginning of therapy (Zein & Itai Danovitch, 2023). It is predicted that the patient’s fundamental problem with alcohol dependence would improve (Yang et al., 2022). She needs to reduce or stop consuming alcohol regularly.
Ethical Consideration
Clinicians are urged to treat persons with drug use problems equally regardless of their gender, color, or any other characteristic (Mistarz et al., 2021). The patient was treated according to the PMHNP’s ethical criterion of fairness.
Decision #2
Selected Decision
It was reasonable to recommend the client visit a psychiatrist for her predisposition for gambling as the second intervention.
Justification
A counselor will use several counseling techniques to address this problem (Mistarz et al., 2021). Among the most popular therapies are CBT, group therapy, and psychodynamic therapy (Taubin et al., 2022). CBT, which teaches patients how to stop gambling and promotes optimistic attitudes, is one of the finest methods to assist patients in overcoming their gambling addictions (Zein & Itai Danovitch, 2023). A three-month follow-up examination demonstrates that, as a consequence of cognitive-behavioral therapy, the gamblers’ habits have dramatically improved (Yang et al., 2022). Additionally, this will instruct them in relapse prevention strategies, help them learn new coping and problem-solving skills, and develop their social skills (Ray et al., 2020).
Reasons to Reject the Other Two Options
It was incorrect to utilize diazepam as a supplementary treatment to naltrexone since it is addictive (Mistarz et al., 2021). The potent quitting smoking medication Chantix should only be administered for a short time and in minimal dosages when combined with naltrexone (Pettorruso et al., 2023).
Expected Outcome
It is predicted that the patient would report decreased gaming tendencies within a few weeks (Zein & Itai Danovitch, 2023). She continued by saying she had been going to Gamblers Anonymous meetings. She says she was inspired by the last organization she belonged to (Antonelli et al., 2022).
Ethical Consideration
According to nursing ethics, every patient must get the same treatment from the nurse without exception. It is crucial to promote patient-centered care with a focus on meeting the needs of the patient (Pettorruso et al., 2023). For instance, a therapist may successfully treat the patient’s major concern in this circumstance, which was gambling (Trick & Le Foll, 2020). The ethical rule of non-maleficence had an impact on the PMHNP’s decision.
Decision #3
Selected Decision
The patient was asked to continue attending Gamblers Anonymous meetings and the decision was made after considering her communication difficulties with her psychotherapist.
Justification
The patient is still highly devoted to her battle against addiction even if she and her therapist did not get along (Taubin et al., 2022). She is inspired as a result to join Gamblers Anonymous. She may now mostly rely on treatment to assist her in overcoming her gambling addiction (Mistarz et al., 2021). Due to this, the therapist and client must discuss their problem for them to guide how to address it and get the most out of group therapy (Ray et al., 2020). Counseling can only be effective when there is a solid therapeutic connection built on trust (Trick & Le Foll, 2020). The issue should be resolved beforehand so that the nurse can concentrate on the sessions that follow (Antonelli et al., 2022). It became vital to reestablish the relationship and trust as a consequence.
Reasons to Reject the Other Two Options
The patient will discontinue psychotherapy if you push her to continue while disregarding her differences with the therapist (Taubin et al., 2022). It is undesirable to quit utilizing naltrexone treatment since it is more successful when sustained over time, particularly in persons with severe drug addiction (Pettorruso et al., 2023).
Expected Outcome
When the client’s conflict with her counselor has been resolved, she will be expected to stop gambling and continue to abstain from alcohol(Ray et al., 2020). She ought to be able to modify her smoking behaviors in collaboration with her therapist (Zein & Itai Danovitch, 2023).
Ethical Considerations
To obtain greater results, psychiatrists are urged to take part in helping their patients form a strong therapeutic relationship (Ray et al., 2020). It’s important to keep neutrality while resolving conflicts between a patient and her counselors and to explain to the patient the importance of focusing on this relationship. Ethics concerns such as nonmaleficence and autonomy also played a part in this decision (Trick & Le Foll, 2020).
Conclusion NURS 6630 ASSESSING AND TREATING PATIENTS WITH IMPULSIVITY, COMPULSIVITY, AND ADDICTION ASSIGNMENT
To provide the best possible care for clients with drug use disorders and addiction, healthcare practitioners must have a solid basis in pharmacology. Before entering the clinic, the woman in the case study was preoccupied with the shame caused by her drinking and gambling addiction. Age, gender, and ethnicity were taken into account while choosing the most effective therapy for the patient’s illness. The initial step was to deliver naltrexone, which is often recommended as the first-line treatment for drug addiction problems and has FDA licensing (Trick & Le Foll, 2020). Due to their brief half-lives and increased risk of negative patient effects, Campral and Disulfiram are inappropriate (Zein & Itai Danovitch, 2023). The woman claimed that she had stopped drinking since the initial injection, despite continuing to smoke and gamble after four weeks (Mistarz et al., 2021). Therefore, it was crucial to suggest that the client gets in touch with a psychologist for assistance with her gambling. It was inappropriate to include either varenicline or diazepam in the client’s treatment plan since both medications are addictive and only modest doses are recommended for stopping smoking (Yang et al., 2022).
The client reported increased symptoms at the next session, but her primary concern was that she detested her therapists (Taubin et al., 2022). Because of this, the client’s problems should be discussed with her counselor as part of the overall treatment plan, and she should be encouraged to keep going to Gamblers Anonymous meetings (Pettorruso et al., 2023). Stopping naltrexone use and ignoring the patient’s disdain for her therapist were both poor decisions (Antonelli et al., 2022).The PMHNP has several ethical issues to keep in mind while making decisions, like protecting the patient’s autonomy and averting bias (Ray et al., 2020). Additional ethical standards that are upheld include fairness and non-maleficence.
References NURS 6630 ASSESSING AND TREATING PATIENTS WITH IMPULSIVITY, COMPULSIVITY, AND ADDICTION ASSIGNMENT
Antonelli, M., Sestito, L., Tarli, C., & Addolorato, G. (2022). Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective? European Journal of Internal Medicine, 103, 13–22. https://doi.org/10.1016/j.ejim.2022.05.016
Mistarz, N., Nielsen, A. S., Andersen, K., Goudriaan, A. E., Skøt, L., Mathiasen, K., Michel, T. M., & Mellentin, A. I. (2021). Brain+ AlcoRecover: A Randomized Controlled Pilot-Study and Feasibility Study of Multiple-Domain Cognitive Training Using a Serious Gaming App for Treating Alcohol Use Disorders. Frontiers in Psychiatry, 12. https://doi.org/10.3389/fpsyt.2021.727001
Pettorruso, M., Di Carlo, F., Romeo, V. M., Jimenez-Murcia, S., Grant, J. E., Martinotti, G., & di Giannantonio, M. (2023). The pharmacological management of gambling disorder: if, when and how. Expert Opinion on Pharmacotherapy. https://doi.org/10.1080/14656566.2023.2172329
Ray, L. A., Meredith, L. R., Kiluk, B. D., Walthers, J., Carroll, K. M., & Magill, M. (2020). Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders. JAMA Network Open, 3(6), e208279. https://doi.org/10.1001/jamanetworkopen.2020.8279
Taubin, D., Wilson, J. C., & Wilens, T. E. (2022). ADHD and Substance Use Disorders in Young People. Child and Adolescent Psychiatric Clinics of North America. https://doi.org/10.1016/j.chc.2022.01.005
Trick, L., & Le Foll, B. (2020). Pharmacological Treatment of Alcohol Use Disorder. Textbook of Addiction Treatment, 123–139. https://doi.org/10.1007/978-3-030-36391-8_10
Yang, W., Singla, R., Maheshwari, O., Fontaine, C. J., & Gil-Mohapel, J. (2022). Alcohol Use Disorder: Neurobiology and Therapeutics. Biomedicines, 10(5), 1192. https://doi.org/10.3390/biomedicines10051192
Zein, M., & Itai Danovitch. (2023). Substance-Related and Addictive Disorders. Springer EBooks, 437–467. https://doi.org/10.1007/978-3-031-15401-0_14
NURS 6630 ASSESSING AND TREATING PATIENTS WITH IMPULSIVITY, COMPULSIVITY, AND ADDICTION ASSIGNMENT Rubric
| NURS_6630_Week10_Assignment1_Rubric | ||||||
| Criteria | Ratings | Pts | ||||
| This criterion is linked to a Learning Outcome Introduction to the case (1 page)Briefly explain and summarize the case for this Assignment. Be sure to include the specific patient factors that may impact your decision making when prescribing medication for this patient. |
|
10 pts | ||||
| This criterion is linked to a Learning Outcome Decision #1 (1–2 pages)• Which decision did you select?• Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.• Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.• What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).• Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples. |
|
20 pts | ||||
| This criterion is linked to a Learning Outcome Decision #2 (1–2 pages)• Which decision did you select?• Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.• Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.• What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).• Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples. |
|
20 pts | ||||
| This criterion is linked to a Learning Outcome Decision #3 (1–2 pages)• Which decision did you select?• Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.• Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.• What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).• Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples. |
|
20 pts | ||||
| This criterion is linked to a Learning Outcome Conclusion (1 page)• Summarize your recommendations on the treatment options you selected for this patient. Be sure to justify your recommendations and support your response with clinically relevant and patient-specific resources, including the primary literature. |
|
15 pts | ||||
| This criterion is linked to a Learning Outcome Written Expression and Formatting – Paragraph Development and Organization: Paragraphs make clear points that support well-developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused—neither long and rambling nor short and lacking substance. A clear and comprehensive purpose statement and introduction are provided that delineate all required criteria. |
|
5 pts | ||||
| This criterion is linked to a Learning Outcome Written Expression and Formatting – English writing standards: Correct grammar, mechanics, and proper punctuation |
|
5 pts | ||||
| This criterion is linked to a Learning Outcome Written Expression and Formatting – The paper follows correct APA format for title page, headings, font, spacing, margins, indentations, page numbers, parenthetical/in-text citations, and reference list. |
|
5 pts | ||||
| Total Points: 100 | ||||||
NURS 6630 ASSESSING AND TREATING PATIENTS WITH IMPULSIVITY, COMPULSIVITY, AND ADDICTION ASSIGNMENT Grading Rubric
| Performance Category | 100% or highest level of performance
100% 16 points |
Very good or high level of performance
88% 14 points |
Acceptable level of performance
81% 13 points |
Inadequate demonstration of expectations
68% 11 points |
Deficient level of performance
56% 9 points
|
Failing level
of performance 55% or less 0 points |
| Total Points Possible= 50 | 16 Points | 14 Points | 13 Points | 11 Points | 9 Points | 0 Points |
| Scholarliness
Demonstrates achievement of scholarly inquiry for professional and academic topics. |
Presentation of information was exceptional and included all of the following elements:
|
Presentation of information was good, but was superficial in places and included all of the following elements:
|
Presentation of information was minimally demonstrated in all of the following elements:
|
Presentation of information is unsatisfactory in one of the following elements:
|
Presentation of information is unsatisfactory in two of the following elements:
|
Presentation of information is unsatisfactory in three or more of the following elements
|
| 16 Points | 14 Points | 13 Points | 11 Points | 9 Points | 0 Points | |
| Application of Course Knowledge
Demonstrate the ability to analyze and apply principles, knowledge and information learned in the outside readings and relate them to real-life professional situations |
Presentation of information was exceptional and included all of the following elements:
|
Presentation of information was good, but was superficial in places and included all of the following elements:
|
Presentation of information was minimally demonstrated in the all of the following elements:
|
Presentation of information is unsatisfactory in one of the following elements:
|
Presentation of information is unsatisfactory in two of the following elements:
|
Presentation of information is unsatisfactory in three of the following elements
|
| 10 Points | 9 Points | 6 Points | 0 Points | |||
| Interactive Dialogue
Initial post should be a minimum of 300 words (references do not count toward word count) The peer and instructor responses must be a minimum of 150 words each (references do not count toward word count) Responses are substantive and relate to the topic. |
Demonstrated all of the following:
|
Demonstrated 3 of the following:
|
Demonstrated 2 of the following:
|
Demonstrated 1 or less of the following:
|
||
| 8 Points | 7 Points | 6 Points | 5 Points | 4 Points | 0 Points | |
| Grammar, Syntax, APA
Points deducted for improper grammar, syntax and APA style of writing. The source of information is the APA Manual 6th Edition Error is defined to be a unique APA error. Same type of error is only counted as one error. |
The following was present:
AND
AND
|
The following was present:
AND/OR
AND/OR
|
The following was present:
AND/OR
AND/OR
|
The following was present:
AND/OR
AND/OR
|
The following was present:
AND/OR
AND/OR
AND/OR
|
The following was present:
AND/OR
AND/OR
|
| 0 Points Deducted | 5 Points Lost | |||||
| Participation
Requirements |
Demonstrated the following:
|
Failed to demonstrate the following:
|
||||
| 0 Points Lost | 5 Points Lost | |||||
| Due Date Requirements | Demonstrated all of the following:
A minimum of one peer and one instructor responses are to be posted within the course no later than Sunday, 11:59 pm MT. |
Demonstrates one or less of the following.
A minimum of one peer and one instructor responses are to be posted within the course no later than Sunday, 11:59 pm MT. |